Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR-215757), a new quinoline-3-carboxamide derivative: studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging stu (Q39680831)
Jump to navigation
Jump to search
scientific article published on May 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR-215757), a new quinoline-3-carboxamide derivative: studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging stu |
scientific article published on May 2012 |
Statements
1 reference
Pharmacokinetics, tolerability, and preliminary efficacy of paquinimod (ABR-215757), a new quinoline-3-carboxamide derivative: studies in lupus-prone mice and a multicenter, randomized, double-blind, placebo-controlled, repeat-dose, dose-ranging stu (English)
1 reference
Anders A Bengtsson
1 reference
Gunnar Sturfelt
1 reference
Christian Lood
1 reference
Lars Rönnblom
1 reference
Bengt Axelsson
1 reference
Birgitta Sparre
1 reference
Helén Tuvesson
1 reference
Marie Wallén Ohman
1 reference
Tomas Leanderson
1 reference
1 May 2012
1 reference
1 reference
1579-1588
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference